|
Aarey Drugs & Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
158.78 Cr.
|
P/BV
|
1.19
|
Book Value (Rs.)
|
46.93
|
|
52 Week High/Low (Rs.)
|
75/31
|
FV/ML
|
10/1
|
P/E(X)
|
33.92
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
1.65
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 1.67 | 1.49 | 2.72 | 2.79 | 2.48 |
| Diluted EPS (Rs.) | 1.67 | 1.49 | 2.72 | 2.79 | 2.80 |
| Cash EPS (Rs.) | 2.27 | 2.11 | 3.36 | 3.18 | 2.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 47.33 | 46.25 | 44.77 | 42.27 | 39.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 47.33 | 46.25 | 44.77 | 42.27 | 39.49 |
| Revenue From Operations / Share (Rs.) | 141.02 | 165.04 | 194.09 | 148.99 | 128.33 |
| PBDIT / Share (Rs.) | 4.07 | 4.12 | 5.52 | 4.98 | 4.24 |
| PBIT / Share (Rs.) | 3.46 | 3.50 | 4.74 | 4.59 | 3.86 |
| PBT / Share (Rs.) | 1.90 | 2.37 | 3.95 | 3.55 | 3.10 |
| Net Profit / Share (Rs.) | 1.67 | 1.49 | 2.58 | 2.79 | 2.48 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 2.88 | 2.49 | 2.84 | 3.34 | 3.30 |
| PBIT Margin (%) | 2.45 | 2.11 | 2.44 | 3.08 | 3.00 |
| PBT Margin (%) | 1.35 | 1.43 | 2.03 | 2.38 | 2.41 |
| Net Profit Margin (%) | 1.18 | 0.90 | 1.32 | 1.86 | 1.93 |
| Return on Networth / Equity (%) | 3.52 | 3.21 | 5.75 | 6.58 | 6.27 |
| Return on Capital Employeed (%) | 7.10 | 7.20 | 10.44 | 10.68 | 9.62 |
| Return On Assets (%) | 1.54 | 1.29 | 2.66 | 2.79 | 2.98 |
| Long Term Debt / Equity (X) | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.23 | 0.32 | 0.12 | 0.18 | 0.19 |
| Asset Turnover Ratio (%) | 1.33 | 1.56 | 2.06 | 1.63 | 1.77 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.70 | 1.61 | 1.74 | 1.65 | 1.81 |
| Quick Ratio (X) | 1.49 | 1.44 | 1.63 | 1.51 | 1.64 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 2.61 | 3.65 | 7.01 | 4.79 | 5.56 |
| Interest Coverage Ratio (Post Tax) (%) | 2.07 | 2.32 | 4.27 | 3.68 | 4.25 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 155.10 | 97.10 | 119.06 | 71.62 | 48.49 |
| EV / Net Operating Revenue (X) | 0.39 | 0.23 | 0.24 | 0.20 | 0.16 |
| EV / EBITDA (X) | 13.59 | 9.29 | 8.50 | 6.15 | 4.89 |
| MarketCap / Net Operating Revenue (X) | 0.31 | 0.14 | 0.21 | 0.15 | 0.10 |
| Price / BV (X) | 0.94 | 0.51 | 0.92 | 0.54 | 0.33 |
| Price / Net Operating Revenue (X) | 0.31 | 0.14 | 0.21 | 0.15 | 0.10 |
| EarningsYield | 0.03 | 0.06 | 0.06 | 0.12 | 0.18 |
